Active, Not Recruiting
Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers
NCT04196465
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Liver Diseases, +6 more
- Locations
-
- Asan Medical Center Seoul, South Korea